Quality of Life Assessment for
Evaluating Benign Prostatic
Hyperplasia Treatments

Fowler, Floyd J.; Barry, Michael J.

doi:10.1159/000474370

Cited by 42 publications

(11 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ten BPH disease-specific questionnaires were identified [1,[6][7][8][9][10][11][17][18][19] and 18 questionnaires measuring sexual functioning and behavior were found [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37]. Referring to definitions of QoL given in the literature [3], four questionnaires were excluded because they were either utility measures [17] or not self-administered [18,19].…”

Section: Literature Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Relative Importance of Sexuality and Quality of Life in Patients with Prostatic Symptoms

Silva¹,

Marquis²,

Deschaseaux³

et al. 1997

Eur Urol

108

View full text Add to dashboard Cite

Section: Literature Reviewmentioning

confidence: 99%

“…In BPH, several specific instruments have been devel oped to measure QoL [6][7][8][9][10][11]. Analysis of their content revealed that no consensus has emerged on the concepts that should be measured in evaluating the benefits that BPH patients can expect from treatment.…”

Section: Introductionmentioning

confidence: 99%

Relative Importance of Sexuality and Quality of Life in Patients with Prostatic Symptoms

Silva¹,

Marquis²,

Deschaseaux³

et al. 1997

Eur Urol

108

View full text Add to dashboard Cite

“…The outcome of treatment for BPE has traditionally been measured using physical variables and symptom scores. Recently, studies have assessed the effect of BPH and its treatments on quality of life [1–7]. However, no previous work has focused on the partners’ attitudes towards this condition, although it seems reasonable to suppose that many of the classic symptoms of BPE may have some effect on the patients’ partner.…”

Section: Introductionmentioning

confidence: 99%

The development and validation of a quality‐of‐life measure to assess partner morbidity in benign prostatic enlargement

Sells

Donovan

Ewings³

et al. 2000

BJU International

View full text Add to dashboard Cite

Objective To investigate morbidity in the partners of patients with benign prostatic enlargement (BPE) by developing and validating a disease-speci®c questionnaire. Patients and methods Phase 1 of the study comprised preliminary interviews with 15 patients who had newly diagnosed BPE, and with their partners, to determine the relevant issues for the partners. In phase 2, using these issues, a questionnaire was produced and tested on the 15 partners. In phase 3 the questionnaire was completed by 90 further partners, 50 at interview and the next 40 by post. As part of the validation process, the partners were also asked to complete the Short-Form-36 questionnaire, and the patients the Internation Prostate Symptom Score (IPSS) and the ICSmale questionnaires. Results In phase 1 all 15 of the partners were affected by the patients' disease and nine issues were identi®ed. In phase 2, of the 90 partners, only one had no morbidity from the patient's symptoms; 71% were worried that the patient may have cancer and 69% concerned that the patient may require an operation. Only six partners were present at the patients' urological consultation. The partners' questionnaire scores were related signi®cantly to the Mental Health and Vitality domains of the SF36 and with the patients' IPSS. Conclusions The study con®rmed the presence of signi®cant morbidity in the partners of patients with BPE. The degree of partner morbidity was related to the severity of the patients' symptoms. Many of the questionnaire issues can be addressed in the consulting room by open discussion with patient and partner.

show abstract

“…Recent evidence suggests that treatment of BPH, even with invasive procedures, such as transurethral resection of the prostate, can actually improve erectile function (81). This improvement may be associated with an improved urinary function and be related to an increase in overall quality of life (95). Certainly, patients who feel better may have more satisfying emotional and physical relationships.…”

Section: Discussionmentioning

confidence: 99%

Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life

Martin¹,

Mulhall²

2005

International Journal of Clinical Practice

View full text Add to dashboard Cite

Benign prostatic hyperplasia is a common genitourinary disorder that increases in incidence with age. Symptoms of this condition include a weak urinary stream, hesitancy, intermittency and sensations of incomplete emptying, as well as frequency, urgency, urge incontinence and nocturia. These symptoms can be ameliorated successfully by a variety of medical treatments - such as alpha(1)-adrenergic blockade and 5-alpha-reductase inhibition - and surgical therapies - including transurethral resection of the prostate and less-invasive procedures. However, many of the treatments are known to result in sexual dysfunction, which can have a negative impact on the patient's quality of life. This must be considered when the physician seeks to determine the appropriate treatment for an individual patient. Current reports suggest that alpha(1)-adrenergic blockade is most likely to improve lower urinary tract symptoms while resulting in the fewest sexual side-effects; 5-alpha-reductase inhibitors appear to be particularly appropriate in men with large prostates. Among surgical therapies, transurethral resection of the prostate remains the gold standard, but is associated with a high incidence of sexual side-effects, especially retrograde ejaculation. Transurethral incision of the prostate, which is an endoscopic procedure, may be as effective as transurethral resection, but results in fewer side-effects. Minimally invasive procedures, including laser ablation or resection of the prostate, transurethral microwave thermotherapy and transurethral needle ablation, are rapidly evolving technologies that have demonstrated promising results, at least in the short term.

show abstract

Quality of Life Assessment for Evaluating Benign Prostatic Hyperplasia Treatments

Cited by 42 publications

References 7 publications

Relative Importance of Sexuality and Quality of Life in Patients with Prostatic Symptoms

Relative Importance of Sexuality and Quality of Life in Patients with Prostatic Symptoms

The development and validation of a quality‐of‐life measure to assess partner morbidity in benign prostatic enlargement

Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life

Contact Info

Product

Resources

About